阿尔茨海默病综合理论的框架
Dmitry V Zaretsky1, Maria V Zaretskaia1
1Zarbio, Chapel Hill, NC 27516, Zarbio Laboratories, Chapel Hill, NC 27516, USA.
Current Alzheimer research
|May 12, 2025
概括
阿尔茨海默病 (AD) 与β-粉样蛋白的细胞吸收增加有关,这导致毒性和聚合. 这种新假设解释了AD的机制,并提出了新的诊断和治疗目标.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 阿尔茨海默病 (AD) 的整合性假设需要通过实验和临床数据进一步阐明.
- 现有的模型不能完全解释粉样蛋白负担,细胞吸收和AD中的神经退行之间的相关性.
研究的目的:
- 通过分析现有数据,解读阿尔茨海默病 (AD) 的整合假设.
- 提出一种新的框架,即粉样蛋白降解毒性假说,解释AD的发病过程.
- 确定当前AD生物标志物的局限性,并建议新的诊断和治疗策略.
主要方法:
- 对粉样蛋白生物标记物和稳定同位素标签动力学 (SILK) 研究的分析.
- 调查通过内细胞分裂吸收β-粉样蛋白及其细胞内作用.
- 模拟细胞吸收,细胞毒性,聚合和AD诊断模式之间的相关性.
主要成果:
- 细胞吸收β-粉样蛋白的增加与AD诊断和神经退行相关.
- β-粉样蛋白的吸收会诱导溶酶体通透,导致细胞毒性和细胞死亡.
- 拟议的粉样蛋白降解毒性假设准确预测AD模式,并解释关键的病理生物学现象.
结论:
- 阿尔茨海默氏病的发病包括粉样片段诱导的溶酶体膜通道形成和随后的细胞损伤.
- 细胞粉样蛋白的吸收是细胞毒性和细胞外聚合物形成的核心,将AD诊断与聚合物密度联系起来.
- 粉样蛋白降解毒性假说为AD病理生物学提供了统一的解释,并突出了潜在的治疗点.
关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.粉样蛋白沉积物 粉样蛋白沉积物在β-氨酸毒性的毒性.细胞吸收细胞吸收.lysosome. lysosome. lysosome. lysosome. lysosome. lysosome. lysosome. lysosome. lysosome. lysosome. lysosome. lysosome. lysosome. lysosome. lysosome. lysosome. lysosome. lysosome. lysosome. lysosome. lysosome. lysosome. lysosome. lysosome. lysosome.更多相关视频
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
7.8K
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
9.2K
相关概念视频
Alzheimer's Disease: Overview
323
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
323
Alzheimer's Disease: Treatment
128
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128
Aging
26
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
26
Dementia
70
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
70
Cognitive Development During Adulthood
28
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
28
Role of Neurotransmitters in Memory
311
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
311
